Intact parathyroid hormone levels higher than 50 pg/mL in patients with stage 3 or 4 CKD are associated with an increased risk of death or the need for renal replacement therapy, data show according to a study presented at ASN’s Renal Week 2009.
Oral alfacalcidol is effective in controlling secondary hyperparathyroidism with an adjusted dose 1.5 times that of oral calcitriol, a study showed.
Cinacalcet treatment following renal transplantation is associated with improved bone remodeling, a study found.
Among older adults, higher parathyroid hormone (PTH) levels are associated with heart failure and lower serum levels of 25-hydroxyvitamin D (25-OHD) are associated with all-cause mortality and myocardial infarction (MI).
The concentration of 25-hydroxyvitamin D (25-OHD) is not independently associated with left ventricular hypertrophy (LVH), researchers have concluded.
Please login or register first to view this content.
